HIGH-DOSE METOCLOPRAMIDE IN CISPLATIN TREATED PATIENTS

被引：0
|
作者：
FRUSTACI, S
TIRELLI, U
TUMOLO, S
VERONESI, A
GALLIGIONI, E
TROVO, M
GRIGOLETTO, E
机构：
来源：
CHEMIOTERAPIA | 1983年 / 2卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [31] The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin
    Umino, Kento
    Hatano, Kaoru
    Ochi, Shin-ichi
    Genda, Harunobu
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Mashima, Kiyomi
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Morita, Kaoru
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Sato, Kazuya
    Oh, Iekuni
    Fujiwara, Shin-ichiro
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (03) : 396 - 400
  • [32] The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin
    Kento Umino
    Kaoru Hatano
    Shin-ichi Ochi
    Harunobu Genda
    Takashi Ikeda
    Shin-ichiro Kawaguchi
    Yumiko Toda
    Shoko Ito
    Takashi Nagayama
    Kiyomi Mashima
    Daisuke Minakata
    Hirofumi Nakano
    Ryoko Yamasaki
    Kaoru Morita
    Chihiro Yamamoto
    Masahiro Ashizawa
    Kazuya Sato
    Iekuni Oh
    Shin-ichiro Fujiwara
    Ken Ohmine
    Kazuo Muroi
    Yoshinobu Kanda
    International Journal of Hematology, 2020, 111 : 396 - 400
  • [33] RANDOMIZED TRIAL FOR THE CONTROL OF ACUTE VOMITING IN CISPLATIN-TREATED PATIENTS - HIGH-DOSE METOCLOPRAMIDE WITH DEXAMETHASONE AND LORAZEPAM AS ADJUNCTS VERSUS HIGH-DOSE ALIZAPRIDE PLUS DEXAMETHASONE AND LORAZEPAM - STUDY OF THE INCIDENCE OF DELAYED EMESIS
    MORENO, I
    ROSELL, R
    ABADESTEVE, A
    BARNADAS, A
    CARLES, J
    RIBELLES, N
    ONCOLOGY, 1991, 48 (05) : 397 - 402
  • [34] A RANDOMIZED TRIAL OF HIGH-DOSE BOLUS METOCLOPRAMIDE VERSUS LOW-DOSE CONTINUOUS INFUSION METOCLOPRAMIDE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
    DANA, BW
    MCDERMOTT, M
    EVERTS, E
    ABDULHAY, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 253 - 256
  • [35] A DOUBLE-BLIND RANDOMIZED CROSS-OVER COMPARISON OF HIGH-DOSE PROCHLORPERAZINE WITH HIGH-DOSE METOCLOPRAMIDE FOR CISPLATIN-INDUCED EMESIS
    AKHTAR, SS
    BANO, ZA
    BHAT, GM
    BHAT, MA
    ONCOLOGY, 1991, 48 (03) : 226 - 229
  • [36] PROTECTION FROM NAUSEA AND VOMITING IN CISPLATIN-TREATED PATIENTS - HIGH-DOSE METOCLOPRAMIDE COMBINED WITH METHYLPREDNISOLONE VERSUS METOCLOPRAMIDE COMBINED WITH DEXAMETHASONE AND DIPHENHYDRAMINE - A STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCHR
    ROILA, F
    TONATO, M
    BASURTO, C
    PICCIAFUOCO, M
    BRACARDA, S
    DONATI, D
    MALACARNE, P
    MONICI, L
    DICOSTANZO, F
    PATOIA, L
    BALLATORI, E
    TOGNONI, G
    DELFAVERO, A
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) : 1693 - 1700
  • [37] THE ADDITION OF ONDANSETRON TO THE COMBINATION OF METOCLOPRAMIDE, DEXAMETHASONE, AND LORAZEPAM DID NOT IMPROVE VOMITING PREVENTION IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
    BALTZER, L
    KRIS, MG
    TYSON, LB
    RIGAS, JR
    PISTERS, KMW
    CANCER, 1994, 73 (03) : 720 - 723
  • [38] CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN PREVENTION OF CISPLATIN-INDUCED EMESIS
    EGROS, F
    DUFOUR, A
    CAZOR, JL
    LANCET, 1992, 340 (8819): : 619 - 619
  • [39] ANTIEMETIC EFFECT OF HIGH-DOSE METOCLOPRAMIDE - REPLY
    HRUSHESKY, WJM
    VONROEMELING, R
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 441 - 441
  • [40] A PHARMACOKINETIC STUDY OF HIGH-DOSE METOCLOPRAMIDE SUPPOSITORIES
    HARDY, F
    WARRINGTON, PS
    MACPHERSON, JS
    HUDSON, SA
    JEFFERSON, GC
    SMYTH, JF
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1990, 15 (01) : 21 - 24
12345